Document Classification

Section Type: RESULTS

Text: At the end of the study, compared with placebo, the levocarnitine-treated patients showed significant improvements in the following parameters : total fat mass (-3. 1 vs -0. 5 kg), total muscle mass (+2. 1 vs +0. 2 kg), total cholesterol (-1. 2 vs +0. 1 mmol/L), LDL-C (-1. 1 vs -0. 2 mmol/L), HDL-C (+0. 2 vs +0. 01 mmol/L), triglycerides (-0. 3 vs 0. 0 mmol/L), apoA1 (-0. 2 vs 0. 0 g/L), and apoB (-0. 3 vs -0. 1 g/L).